4.2 Article

Congenital muscular dystrophy with glycosylation defects of α-dystroglycan in Japan

Journal

NEUROMUSCULAR DISORDERS
Volume 15, Issue 5, Pages 342-348

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2005.01.009

Keywords

alpha-dystroglyean (alpha-DG); Fukuyama-type congenital muscular dystrophy (FCMD); congenital muscular dystrophy 1C (MDC1C); muscle-eye-brain disease (MEB); Walker-Warburg syndrome (WWS); glycosylation; fukutin; FKRP; POMGnT1; POMT1; LARGE

Ask authors/readers for more resources

Glycosylation defects of alpha-dystroglyean (alpha-DG) cause various muscular dystrophies. We performed clinical, pathological and genetic analyses of 62 Japanese patients with congenital muscular dystrophy, whose skeletal muscle showed deficiency of glycosylated form of alpha-DG. We found, the first Japanese patient with congenital muscular dystrophy 1C with a novel compound heterozygous mutation in the fukutin-related protein gene. Fukuyama-type congenital muscular dystrophy was genetically confirmed in 54 of 62 patients. Two patients with muscle-eye-brain disease and one Walker-Warburg syndrome were also genetically confirmed. Four patients had no mutation in any known genes associated with glycosylation of a-DG. Interestingly, the molecular mass of a-DG in the skeletal muscle was similar and was reduced to similar to 90 kDa among these patients, even though the causative gene and the clinico-pathological severity were different. This result suggests that other factors can modify clinical features of the patients with glycosylation defects of a-DG. (c) 2005 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available